Junya Fukuoka - Concepedia

Author

Junya Fukuoka

Also Known As

Andrey Bychkov, Dan Su, Fukuoka J, Fukuoka, Junya, Hikaru Seto, Hoa H.N. Pham, Hoa Pham, J Fukuoka, J. Fukuoka, JUNYA FUKUOKA

501

Publications

12.3K

Citations

H-Index

174

Concepts

All Affiliations

Nagasaki University Toyama University Hospital University of Toyama Nagasaki University Hospital Tosei General Hospital

About

Junya Fukuoka is an author at Nagasaki University specializing in medicine, pathology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	66	4K
2	Health Sciences	9	9	191
3	Engineering	8	8	488
4	Public Health	2	2	44
5	Natural Sciences	1	1	32

Junya Fukuoka

167

Publications

9.6K

Citations

H-Index

Page 1

	Year	Citations
Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival Maria Teresa Landi, Tatiana Dracheva, Melissa Rotunno, PLoS ONE	2008	686
Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study Simon Walsh, Athol U. Wells, Sujal R. Desai, The Lancet Respiratory Medicine Advanced Lung DiseaseClinical EpidemiologyDiagnosisMulticentre EvaluationOutcomes Research	2016	433
Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore Teri J. Franks, Pek Yoon Chong, Paul Chui, Human Pathology Acute Lung InjuryRespiratory DiseasesAcute Respiratory Distress SyndromePathologyRespiratory Infection	2003	428
Early Immune-Related Adverse Events and Association with Outcome in Advanced Non–Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study Shunsuke Teraoka, Daichi Fujimoto, Takeshi Morimoto, Journal of Thoracic Oncology OncologyCancer EpidemiologyCancer ManagementImmunologyTumor Immunity	2017	368
Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients Ilseon Hwang, Jeong Won Kim, Kris Ylaya, Journal of Translational Medicine	2020	242
Napsin A, a New Marker for Lung Adenocarcinoma, Is Complementary and More Sensitive and Specific Than Thyroid Transcription Factor 1 in the Differential Diagnosis of Primary Pulmonary Carcinoma: Evaluation of 1674 Cases by Tissue Microarray Bradley M. Turner, Philip T. Cagle, Irma M. Sáinz, Archives of Pathology & Laboratory Medicine	2012	230
Chromatin Remodeling Factors and BRM/BRG1 Expression as Prognostic Indicators in Non-Small Cell Lung Cancer Junya Fukuoka, Takeshi Fujii, Joanna H. Shih, Clinical Cancer Research Lung AdenocarcinomaPathologyFavorable PrognosisTumor BiologyOncology	2004	212
Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403) Kenji Tamura, Isamu Okamoto, Tatsuhiko Kashii, British Journal of Cancer	2008	203
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma Xin Hu, Junya Fujimoto, Lisha Ying, Nature Communications	2019	181
Evaluation of Two Phosphorylation Sites Improves the Prognostic Significance of Akt Activation in Non–Small-Cell Lung Cancer Tumors Junji Tsurutani, Junya Fukuoka, Hiroko Tsurutani, Journal of Clinical Oncology	2005	180

Page 1